Astrazeneca (AZN) Gross Profit (2009 - 2026)
Astrazeneca's Gross Profit was $13.26 billion in Q3 2026, up 7.0% from $12.39 billion a year earlier and up 3.1% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Gross Profit (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's Gross Profit was $51.12 billion through Sep 30, 2026, up 6.7% year-over-year; for FY2025, it was $48.11 billion, up 9.7% from FY2024.
- Gross Profit has now increased for seven consecutive years, with a five-year compound annual growth rate of 17.7% (FY2020 to FY2025).
- In earlier years, Gross Profit was $43.87 billion in FY2024 (+16.8%), $37.54 billion in FY2023 (+17.5%), $31.96 billion in FY2022 (+27.9%) and $24.98 billion in FY2021 (+17.2%).
- The Q3 2026 figure marks the highest quarterly Gross Profit in data going back to Q1 2009.
- Compared with a year earlier, Gross Profit has increased for 32 straight quarters, with growth averaging 11.3% over the last eight quarters.
- Over the past five years, the year-over-year growth in Gross Profit ranged from 1.8% (Q4 2025) to 44.4% (Q1 2022).
- Per Business Quant data, AZN's Gross Profit in the three quarters before Q3 2026 was $12.86 billion (Q2 2026), $12.61 billion (Q1 2026) and $12.39 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.26 Bn |
| Jun 30, 2026 | 12.86 Bn |
| Mar 31, 2026 | 12.61 Bn |
| Dec 31, 2025 | 12.39 Bn |
| Sep 30, 2025 | 12.39 Bn |
| Jun 30, 2025 | 11.98 Bn |
| Mar 31, 2025 | 11.35 Bn |
| Dec 31, 2024 | 12.17 Bn |
| Sep 30, 2024 | 10.48 Bn |
| Jun 30, 2024 | 10.76 Bn |
| Mar 31, 2024 | 10.46 Bn |
| Dec 31, 2023 | 9.72 Bn |
| Sep 30, 2023 | 9.40 Bn |
| Jun 30, 2023 | 9.46 Bn |
| Mar 31, 2023 | 8.97 Bn |
| Dec 31, 2022 | 8.31 Bn |
| Sep 30, 2022 | 8.00 Bn |
| Jun 30, 2022 | 7.77 Bn |
| Mar 31, 2022 | 7.88 Bn |
| Dec 31, 2021 | 7.39 Bn |
API Access
Astrazeneca Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();